Invesco’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-227,331
| Closed | -$2.83M | – | 3827 |
|
|
2016
Q4 | $2.83M | Buy |
+227,331
| New | +$2.74M | ﹤0.01% | 2345 |
|
|
2016
Q3 | – | Sell |
-857,630
| Closed | -$6.34M | – | 3712 |
|
|
2016
Q2 | $6.34M | Buy |
857,630
+842,317
| +5,501% | +$6.32M | ﹤0.01% | 1748 |
|
|
2016
Q1 | $98K | Sell |
15,313
-25,960
| -63% | -$146K | ﹤0.01% | 3644 |
|
|
2015
Q4 | $258K | Buy |
41,273
+4,228
| +11% | +$27.7K | ﹤0.01% | 3501 |
|
|
2015
Q3 | $216K | Sell |
37,045
-2,559,601
| -99% | -$19.7M | ﹤0.01% | 3554 |
|
|
2015
Q2 | $21.5M | Sell |
2,596,646
-231,449
| -8% | -$2.05M | 0.01% | 1178 |
|
|
2015
Q1 | $23.3M | Buy |
2,828,095
+2,064,874
| +271% | +$15.3M | 0.01% | 1126 |
|
|
2014
Q4 | $5.24M | Buy |
+763,221
| New | +$4.77M | ﹤0.01% | 1876 |
|
|
2014
Q2 | – | Sell |
-7,700
| Closed | -$62K | – | 4114 |
|
|
2014
Q1 | $62K | Buy |
7,700
+6,827
| +782% | +$53.2K | ﹤0.01% | 3933 |
|
|
2013
Q4 | $6K | Sell |
873
-1,802,526
| -100% | -$9.73M | ﹤0.01% | 4252 |
|
|
2013
Q3 | $33.2M | Buy |
1,803,399
+337,284
| +23% | +$6.55M | 0.01% | 954 |
|
|
2013
Q2 | $25.6M | Buy |
+1,466,115
| New | +$26M | 0.01% | 1015 |
|
Other funds holding ARIA
Invesco's ARIA Position: Q1 2017 in Review
Invesco sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 227,331 shares — an estimated $2.83M sold.
Invesco first reported a position in ARIA in Q2 2013 and held it in 12 quarters. The position peaked at $33.2M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Invesco reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Invesco sold 227,331 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2.83M.
- Invesco first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
- Invesco's Ariad Pharmaceuticals Inc position peaked at $33.2M in Q3 2013.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Invesco's 13F filing for Q1 2017, filed 15 May 2017.